RUA Life Sciences plc (AIM: RUA)

Market Cap	8.07M
Revenue (ttm)	2.92M
Net Income (ttm)	206.00K
Shares Out	62.06M
EPS (ttm)	0.00
PE Ratio	33.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	211,856
Open	13.48
Previous Close	13.00
Day's Range	13.48 - 13.48
52-Week Range	8.50 - 15.70
Beta	1.10
RSI	71.44
Earnings Date	Mar 12, 2025

About RUA Life Sciences

RUA Life Sciences plc, together with its subsidiaries, engages in the provision of polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates through Biomaterials, Contract Manufacture, Vascular, and Structural Heart segments. The Biomaterials segment operates as depository of the Intellectual Property and licensing rights to a range of biostable and implantable polymers, including Elast-Eon and ECSil. The Contract Manufacture segment provides sub-contract manufacturin...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 40
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: RUA

Financial Performance

In 2023, RUA Life Sciences's revenue was 2.19 million, an increase of 0.55% compared to the previous year's 2.18 million. Losses were -1.44 million, -28.11% less than in 2022.